Company intelligence / Profile preview

Fisons

Ipswich, United Kingdomen.wikipedia.org ↗

Ownership: Private
Development stage: Commercial

Overview

At its peak, Fisons was a major UK pharmaceutical and chemical company with global sales of drugs such as sodium cromoglycate for asthma/allergies and iron dextran for anemia. Loss of key US licenses in the early '90s led to decline before acquisition.

Therapeutic areas: HematologyPulmonologyImmunology
Modalities: Small molecule
Industry: Pharma

Partnerships

Agreements with Shell Chemical Company Ltd for ammonia supply during fertilizer era.

Beyond the preview

Go deeper on Fisons.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fisons.

Explore the full profile